Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol I (Q46809317)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol I |
scientific article |
Statements
1 reference
Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol I (English)
1 reference
Laura F Hutchins
1 reference
Stephanie J Green
1 reference
Peter M Ravdin
1 reference
Danika Lew
1 reference
Silvana Martino
1 reference
Martin Abeloff
1 reference
Alan P Lyss
1 reference
Craig Allred
1 reference
Saul E Rivkin
1 reference
C Kent Osborne
1 reference
1 November 2005
1 reference
1 reference
23
1 reference
33
1 reference
8313-8321
1 reference
Identifiers
1 reference
1 reference